Investigational Drug Information for Sulforaphane
✉ Email this page to a colleague
What is the development status for investigational drug Sulforaphane?
Sulforaphane is an investigational drug.
There have been 43 clinical trials for Sulforaphane.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Disease, Prostatic Neoplasms, and Autistic Disorder. The leading clinical trial sponsors are Johns Hopkins University, National Cancer Institute (NCI), and Central South University.
There are five hundred and thirty-three US patents protecting this investigational drug and three international patents.
Summary for Sulforaphane
| US Patents | 533 |
| International Patents | 3,325 |
| US Patent Applications | 1,787 |
| WIPO Patent Applications | 1,073 |
| Japanese Patent Applications | 75 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 77 |
Recent Clinical Trials for Sulforaphane
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease | Nutramax Laboratories, Inc. | Phase 2 |
| Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease | University of Virginia | Phase 2 |
Clinical Trial Summary for Sulforaphane
Top disease conditions for Sulforaphane
Top clinical trial sponsors for Sulforaphane
US Patents for Sulforaphane
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulforaphane | ⤷ Try a Trial | Antibody drug conjugates | Novartis AG (Basel, CH) | ⤷ Try a Trial |
| Sulforaphane | ⤷ Try a Trial | Combined application of isothiocyanate compound and anti-cancer medicine | JC (Wuxi) Company, Inc. (Wuxi, Jiangsu, CN) | ⤷ Try a Trial |
| Sulforaphane | ⤷ Try a Trial | Seaweed extracts, unsaturated fatty acids, and methods of treatment | University of Florida Research Foundation, Incorporated (Gainesville, FL) Smithsonian Institution (Washington, DC) | ⤷ Try a Trial |
| Sulforaphane | ⤷ Try a Trial | Anti-CS1 antibodies and antibody drug conjugates | AbbVie Biotherapeutics Inc. (Redwood City, CA) | ⤷ Try a Trial |
| Sulforaphane | ⤷ Try a Trial | Nutritional composition for promoting gut microbiota balance and health | Nestec S.A. (Vevey, CH) | ⤷ Try a Trial |
| Sulforaphane | ⤷ Try a Trial | Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections | EMORY UNIVERSITY (Atlanta, GA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulforaphane
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulforaphane | Argentina | AR102649 | 2034-11-14 | ⤷ Try a Trial |
| Sulforaphane | Australia | AU2015347015 | 2034-11-14 | ⤷ Try a Trial |
| Sulforaphane | Brazil | BR112017009813 | 2034-11-14 | ⤷ Try a Trial |
| Sulforaphane | Canada | CA2967188 | 2034-11-14 | ⤷ Try a Trial |
| Sulforaphane | Chile | CL2017001217 | 2034-11-14 | ⤷ Try a Trial |
| Sulforaphane | China | CN108064244 | 2034-11-14 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
